Cell & Gene Therapies: A Regulatory Update

Return to Insights Center

Related Insights

Podcast

Rare endpoints: Delivering on unmet patient needs

May 7, 2024

Podcast

CAR-T boxed warnings: What comes next?

Mar 6, 2024

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Blog

CAR-T boxed warnings: regulatory precedents and opportunities

Feb 9, 2024

Blog

CAR-T product development: an assessment of FDA’s final guidance for industry

Feb 27, 2024

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Article

Three ways to improve your chances that insurers will pay for a new CGT

Feb 18, 2021

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Blog

SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Aug 24, 2022

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Podcast

RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry

Jun 16, 2022